Respiratory syncytial virus: promising progress against a leading cause of pneumonia

Código QR

Respiratory syncytial virus: promising progress against a leading cause of pneumonia

Guardado en:

Detalles Bibliográficos
Autores principales:	Amy Sarah Ginsburg, Padmini Srikantiah
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/dbba4de2d995483fb579e182e01e7ec3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

A morphological transformation in respiratory syncytial virus leads to enhanced complement deposition
por: Jessica P Kuppan, et al.
Publicado: (2021)

Severe respiratory disease caused by human respiratory syncytial virus impairs language learning during early infancy
por: Marcela Peña, et al.
Publicado: (2020)

Cryo-EM structure of the respiratory syncytial virus RNA polymerase
por: Dongdong Cao, et al.
Publicado: (2020)

Meteorological drivers of respiratory syncytial virus infections in Singapore
por: Sheikh Taslim Ali, et al.
Publicado: (2020)

Respiratory Syncytial Virus-Induced Oxidative Stress Leads to an Increase in Labile Zinc Pools in Lung Epithelial Cells
por: Naseem Ahmed Khan, et al.
Publicado: (2020)

Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
por: Agata Antepowicz, et al.
Publicado: (2021)

Clinical Epidemiological Characteristics and Risk Factors for Severe Bronchiolitis Caused by Respiratory Syncytial Virus in Vietnamese Children
por: Sang Ngoc Nguyen, et al.
Publicado: (2021)

Epidemic dynamics of respiratory syncytial virus in current and future climates
por: Rachel E. Baker, et al.
Publicado: (2019)

Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor
por: Dirk Roymans, et al.
Publicado: (2017)

Severe acute respiratory syndrome coronavirus 2 and respiratory syncytial virus coinfection in children
por: Milad Zandi, et al.
Publicado: (2021)

Surveillance of respiratory syncytial virus infections in adults, Austria, 2017 to 2019
por: Lorenz Schubert, et al.
Publicado: (2021)

Airway response to respiratory syncytial virus has incidental antibacterial effects
por: Charles J. Sande, et al.
Publicado: (2019)

Assessment and optimization of respiratory syncytial virus prophylaxis in Connecticut, 1996–2013
por: Ben Artin, et al.
Publicado: (2021)

An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus
por: Armando Zuniga, et al.
Publicado: (2021)

Immune response to respiratory syncytial virus infection (<i>Orthopneumovirus</i>)
por: A. A. Nikonova, et al.
Publicado: (2021)

Development of surface engineered antigenic exosomes as vaccines for respiratory syncytial virus
por: Suyeon Hong, et al.
Publicado: (2021)

Rhinovirus-associated wheezing in infancy Comparison with respiratory syncytial virus bronchiolitis
por: Zamorano R.,Juanita
Publicado: (2005)

Acute respiratory infections in hospitalized children in Vientiane, Lao PDR – the importance of Respiratory Syncytial Virus
por: Van Hoan Nguyen, et al.
Publicado: (2017)

Advancing drug innovation for neglected diseases-criteria for lead progression.
por: Solomon Nwaka, et al.
Publicado: (2009)

Utility of the Global Respiratory Severity Score for predicting the need for respiratory support in infants with respiratory syncytial virus infection.
por: Jun Kubota, et al.
Publicado: (2021)

Role of CCR3 in respiratory syncytial virus infection of airway epithelial cells
por: Vincent Wellemans, et al.
Publicado: (2021)

Functional organization of cytoplasmic inclusion bodies in cells infected by respiratory syncytial virus
por: Vincent Rincheval, et al.
Publicado: (2017)

Genetic diversity and molecular evolution of human respiratory syncytial virus A and B
por: Jie-Mei Yu, et al.
Publicado: (2021)

Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection
por: Pooja Munnilal Tiwari, et al.
Publicado: (2018)

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
por: Asunci&oacute;n Mej&iacute;as, et al.
Publicado: (2008)

Respiratory Syncytial Virus Infection Induces Expression of Inducible Nitric Oxide Synthase, CD3, and CD8 in Naturally Occurring Pneumonia in Lambs
por: Yaman Turan, et al.
Publicado: (2021)

Clinical outcomes of adults hospitalized for laboratory confirmed respiratory syncytial virus or influenza virus infection.
por: Magdalena Chorazka, et al.
Publicado: (2021)

ROLE OF PREEXISTING VIRUS-SPECIFIC IgG IN PRIMARY DISEASE AND IN REINFECTION WITH RESPIRATORY SYNCYTIAL VIRUS
por: V. Z. Krivitskaya, et al.
Publicado: (2014)

Schistosoma mansoni egg-derived extracellular vesicles: A promising vaccine candidate against murine schistosomiasis.
por: Shereen F Mossallam, et al.
Publicado: (2021)

Factors Associated with Severe Lower Respiratory Tract Infection from Respiratory Syncytial Virus (RSV) in Thai Children
por: Atipotsawee Tungsupreechameth, et al.
Publicado: (2021)

Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus
por: Gu-Lung Lin, et al.
Publicado: (2021)

Author Correction: An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus
por: Armando Zuniga, et al.
Publicado: (2021)

Integrated omics endotyping of infants with respiratory syncytial virus bronchiolitis and risk of childhood asthma
por: Yoshihiko Raita, et al.
Publicado: (2021)

Viral N 6-methyladenosine upregulates replication and pathogenesis of human respiratory syncytial virus
por: Miaoge Xue, et al.
Publicado: (2019)

Respiratory syncytial virus B sequence analysis reveals a novel early genotype
por: Juan C. Muñoz-Escalante, et al.
Publicado: (2021)

Respiratory syncytial virus promotes Moraxella catarrhalis-induced ascending experimental otitis media.
por: M Elizabeth Brockson, et al.
Publicado: (2012)

Macrophages are required for dendritic cell uptake of respiratory syncytial virus from an infected epithelium.
por: Kelechi Ugonna, et al.
Publicado: (2014)

Author Correction: Airway response to respiratory syncytial virus has incidental antibacterial effects
por: Charles J. Sande, et al.
Publicado: (2019)

Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model
por: Jorge C. G. Blanco, et al.
Publicado: (2018)

Nanodiscs as a therapeutic delivery agent: inhibition of respiratory syncytial virus infection in the lung
por: Numata M, et al.
Publicado: (2013)